TrialTheScientificWorldJournal2012

The efficacy of pramipexole, a dopamine receptor agonist, as an adjunctive treatment in treatment-resistant depression: an open-label trial.

Hiroaki Hori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.